Pivotal Life Sciences
5 people tracked
Investment thesis
Invests from early venture through public markets, focusing on CNS, oncology and rare-disease therapeutics, offering a cross-border U.S.–China platform and an evergreen Hong Kong-backed structure.
Team · 5 people
from the firm's websiteJeni Lee combines award-winning academic research (UC Davis 2016 Best Doctoral Dissertation for the first biomechanical device to fabricate native-like cartilage) with co-founding ViVita and biotech analysis at Aquilo Capital.
Peter Bisgaard combines rare cross‑Atlantic life‑science investing experience—starting in Denmark in 2001 and relocating to build a US team—with an M.Sc. in engineering, postgraduate mathematical‑modelling training, and McKinsey finance/M&A experience.
Rob Hopfner pairs R.Ph., Ph.D., and M.B.A. credentials with multi-stage investing experience to build a full‑stack platform supporting biotech companies through public markets and prioritizing downstream commercial and M&A demand.
Tony Ho, unusually academically accomplished, discovered acute motor axonal neuropathy, has 80+ publications, led first‑in‑class CRISPR therapies into clinical trials, and oversaw AstraZeneca Phase 3 programs driving Lynparza and Imfinzi.
Glenn Batchelder is an operator-turned-investor who built three biotechs (Acceleron Pharma, BIND Biosciences, Civitas Therapeutics) to strategic exits and remains a hands-on company builder as Executive Chair and board member.
Frequently asked questions
- What sectors does Pivotal Life Sciences focus on?
- Pivotal Life Sciences focuses on Biotech, Healthtech, Medical Devices.
- Does Pivotal Life Sciences lead rounds?
- Pivotal Life Sciences typically participates in rounds rather than leading them.
Similar investors
Granatus Ventures is a venture capital firm that backs startups worldwide leveraging Armenia's potential as an emerging technology hub.
Kleiner Perkins is a venture capital firm that backs founders across technology and life sciences, with a portfolio of companies from early stage through growth.
Osage University Partners (OUP) is a venture capital firm that invests in startups emerging from leading research labs and universities, spanning technology and life sciences.
Sunstone Life Science Ventures is an independent European venture capital firm focused on early-stage life science companies developing novel therapeutics for humans.
Third Rock Ventures is a venture capital firm that discovers, launches, and builds life sciences and biotechnology companies developing novel medicines and therapies.